Assessing Postoperative Phosphate and Calcium/Phosphate Ratio as Surrogates for Parathyroid Hormone Following Total Thyroidectomy
Otolaryngology–Head and Neck Surgery · 2024
DOI: 10.1002/ohn.703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2024. Verfasst von Catharine Kappauf und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Thyroidectomy, Parathyroid Hormone, Phosphates, Calcium. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objective
Evaluate utility of postoperative phosphate and calcium/phosphate ratio (Ca/P) as surrogates for parathyroid hormone (PTH) following total thyroidectomy. Study Design Retrospective cohort study.
Setting
Tertiary care hospital.
Methods
We retrospectively reviewed patients 18 years or older who underwent total thyroidectomy in a tertiary care hospital by a single surgeon from 2015 through 2021. Patients with incomplete data, pre‐existing hypoparathyroidism, vitamin D deficiency, or renal failure were excluded. All patients had PTH drawn within 4 hours of surgery and serum calcium, albumin, and phosphate levels on postoperative Day 1. Corrected calcium was used to calculate a Ca/P. Receiver operating characteristic (ROC) curves were generated to compare phosphate level or Ca/P with PTH. Each possible surrogate was assessed relative to PTH cutoffs of less than 5, 10, 15, and 20 pg/mL. A good screening test was defined as having an area under the curve (AUC) greater than 0.8.
Results
A total of 185 patients underwent total thyroidectomy with 1 fellowship‐trained otolaryngologist. Most patients were female (62%), median age 48 years. Most surgeries were performed for cancer (68%). Six (3.2%) patients required IV calcium supplementation and 2 (1.1%) required readmission for symptomatic hypocalcemia. ROC curves comparing phosphate and Ca/P to PTH at the listed cutoffs demonstrated AUC ranging from 0.55 to 0.66 and 0.61 to 0.79, respectively. None met the threshold for a good screening test.
Conclusion
Postoperative phosphate and Ca/P ratio are not surrogates for PTH levels following total thyroidectomy. More research is needed to identify cost‐effective strategies for postoperative calcium monitoring in patients undergoing total thyroidectomy. Level of evidence Retrospective cohort study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Thyroid, Head and Neck Cancer (THANC) Foundation, New York, New York, USA.
- Internal Medicine Department, Division of Endocrinology, Dr. Jose E. González, Universidad Autónoma de Nuevo León San Nicolás de los Garza, Mexico.
ORCID-Profile: Catharine Kappauf
Zitieren
APA
Kappauf, C., Gold, B., Gonzalez-Velazquez, C., Xing, M. H., O'Malley, Q. F., Sandler, M., & Chai, R. L. (2024). Assessing Postoperative Phosphate and Calcium/Phosphate Ratio as Surrogates for Parathyroid Hormone Following Total Thyroidectomy. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.703
Vancouver
Kappauf C, Gold B, Gonzalez-Velazquez C, Xing MH, O'Malley QF, Sandler M, et al. Assessing Postoperative Phosphate and Calcium/Phosphate Ratio as Surrogates for Parathyroid Hormone Following Total Thyroidectomy. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.703
BibTeX
@article{Kappauf2024,
author = {Kappauf, Catharine and Gold, Brandon and Gonzalez-Velazquez, Camilo and Xing, Monica H and O'Malley, Quinn F and Sandler, Mykayla and Chai, Raymond L},
title = {Assessing Postoperative Phosphate and Calcium/Phosphate Ratio as Surrogates for Parathyroid Hormone Following Total Thyroidectomy},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
doi = {10.1002/ohn.703}
}
EUVIMED